TY - JOUR
T1 - Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency
T2 - An observational Israeli-German cohort study
AU - Limperger, Verena
AU - Klostermeier, Ulrich C.
AU - Kenet, Gili
AU - Holzhauer, Susanne
AU - Alhenc Gelas, Martine
AU - Finckh, Ulrich
AU - Junker, Ralf
AU - Heller, Christine
AU - Zieger, Barbara
AU - Kurnik, Karin
AU - Knöfler, Ralf
AU - Mesters, Rolf
AU - Halimeh, Susan
AU - Nowak-Göttl, Ulrike
N1 - Publisher Copyright:
© 2014 John Wiley & Sons Ltd.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Venous thromboembolism [TE] is a multifactorial disease and protein C deficiency [PCD] constitutes a major risk factor. In the present study the prevalence of PCD and the clinical presentation at TE onset, including neonatal purpura fulminans, in a cohort of children are reported. In 367 unselected children (0·1-19 years) recruited between July 1996 and December 2013, a comprehensive thrombophilia screening was performed along with recording of anamnestic data. Twenty-five of 338 children (7·4%) had PCD. Mean age at first TE onset was 10 years (range 0·1-18). Leading thromboembolic manifestations were neonatal purpura fulminans (n = 5), TE of cerebral veins (n = 3), stroke (n = 2) deep veinthrombosis (DVT) of the leg (n = 10), DVT & pulmonary embolism (n = 2) and DVT & pelvic veins (n = 3). Concomitant risk factors for TE were identified in 12 patients, whereas 13 children spontaneously developed TE. A positive family history of DVT was found in 10 children. In this unselected cohort of paediatric patients with symptomatic TE the overall prevalence of PCD was 7·4%; 1·5% presented with neonatal purpura fulminans. Given its clinical implication for patients and family members, thrombophilia testing should be performed and the benefit of medical or educational interventions should be evaluated in this high-risk population.
AB - Venous thromboembolism [TE] is a multifactorial disease and protein C deficiency [PCD] constitutes a major risk factor. In the present study the prevalence of PCD and the clinical presentation at TE onset, including neonatal purpura fulminans, in a cohort of children are reported. In 367 unselected children (0·1-19 years) recruited between July 1996 and December 2013, a comprehensive thrombophilia screening was performed along with recording of anamnestic data. Twenty-five of 338 children (7·4%) had PCD. Mean age at first TE onset was 10 years (range 0·1-18). Leading thromboembolic manifestations were neonatal purpura fulminans (n = 5), TE of cerebral veins (n = 3), stroke (n = 2) deep veinthrombosis (DVT) of the leg (n = 10), DVT & pulmonary embolism (n = 2) and DVT & pelvic veins (n = 3). Concomitant risk factors for TE were identified in 12 patients, whereas 13 children spontaneously developed TE. A positive family history of DVT was found in 10 children. In this unselected cohort of paediatric patients with symptomatic TE the overall prevalence of PCD was 7·4%; 1·5% presented with neonatal purpura fulminans. Given its clinical implication for patients and family members, thrombophilia testing should be performed and the benefit of medical or educational interventions should be evaluated in this high-risk population.
KW - Children
KW - Genetics
KW - Protein C deficiency
KW - Purpura fulminans
UR - http://www.scopus.com/inward/record.url?scp=84912047059&partnerID=8YFLogxK
U2 - 10.1111/bjh.13039
DO - 10.1111/bjh.13039
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 25039884
AN - SCOPUS:84912047059
SN - 0007-1048
VL - 167
SP - 385
EP - 393
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 3
ER -